Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
16 08 2021
Historique:
pubmed: 17 8 2021
medline: 8 1 2022
entrez: 16 8 2021
Statut: epublish

Résumé

This study analysed the reported incidence of COVID-19 and associated epidemiological and socio-economic factors in the WHO African region. Data from COVID-19 confirmed cases and SARS-CoV-2 tests reported to the WHO by Member States between 25 February and 31 December 2020 and publicly available health and socio-economic data were analysed using univariate and multivariate binomial regression models. The overall cumulative incidence was 1846 cases per million population. Cape Verde (21 350 per million), South Africa (18 060 per million), Namibia (9840 per million), Eswatini (8151 per million) and Botswana (6044 per million) recorded the highest cumulative incidence, while Benin (260 per million), Democratic Republic of Congo (203 per million), Niger (141 cases per million), Chad (133 per million) and Burundi (62 per million) recorded the lowest. Increasing percentage of urban population (β = -0.011, P = 0.04) was associated with low cumulative incidence, while increasing number of cumulative SARS-CoV-2 tests performed per 10 000 population (β = 0.0006, P = 0.006) and the proportion of population aged 15-64 years (adjusted β = 0.174, P < 0.0001) were associated with high COVID-19 cumulative incidence. With limited testing capacities and overwhelmed health systems, these findings highlight the need for countries to increase and decentralise testing capacities and adjust testing strategies to target most at-risk populations.

Identifiants

pubmed: 34392872
doi: 10.1017/S095026882100193X
pii: S095026882100193X
pmc: PMC8712961
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e256

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Lancet. 2020 May 30;395(10238):1669
pubmed: 32473665
Trends Immunol. 2020 Dec;41(12):1100-1115
pubmed: 33132005
J Microbiol Immunol Infect. 2020 Jun;53(3):371-372
pubmed: 32147409
BMJ Open. 2019 Dec 9;9(12):e031031
pubmed: 31822541
Int J Health Plann Manage. 2020 Nov;35(6):1302-1305
pubmed: 32790138
GeoJournal. 2021 Mar 3;:1-19
pubmed: 33678946
GeoJournal. 2020 Aug 13;:1-15
pubmed: 32836703
J Clin Med. 2020 Aug 04;9(8):
pubmed: 32759719
Life Sci. 2020 Oct 1;258:118202
pubmed: 32758625
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32675230
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Lancet Microbe. 2020 May;1(1):e12
pubmed: 32835324
Public Health Pract (Oxf). 2020 Nov;1:100038
pubmed: 34173573
Epidemiol Infect. 2019 Nov 11;147:e299
pubmed: 31709961
Ann Intern Med. 2020 Nov 3;173(9):752-753
pubmed: 32551812
Biosecur Bioterror. 2013 Sep;11(3):163-9
pubmed: 24041192
Int J Gen Med. 2019 Nov 06;12:395-403
pubmed: 31819592
Nat Med. 2020 Jul;26(7):996-999
pubmed: 32528153
AAS Open Res. 2020 Apr 17;3:4
pubmed: 32399515
J Ovarian Res. 2020 Nov 24;13(1):137
pubmed: 33234144
J Glob Health. 2020 Dec;10(2):020348
pubmed: 33110546

Auteurs

Franck Mboussou (F)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Benido Impouma (B)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.
College of Public Health, University of South Florida, Tampa, Florida, USA.

Bridget Farham (B)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Caitlin M Wolfe (CM)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.
Institute of Global Health, University of Geneva, Geneva, Switzerland.

George Sie Williams (GS)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Roland Ngom (R)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Milse Nzingou (M)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Aziza Merzouki (A)

College of Public Health, University of South Florida, Tampa, Florida, USA.

Erol Orel (E)

College of Public Health, University of South Florida, Tampa, Florida, USA.

Yahaya Ali Ahmed (YA)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Olivia Keiser (O)

College of Public Health, University of South Florida, Tampa, Florida, USA.

Matshidiso R Moeti (MR)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH